Instituto Nacional De Salud Mental

Instituto Nacional De Salud Mental "Honorio Delgado - Hideyo Noguchi" company information, Employees & Contact Information

Updated June 2026

Quick answer

Instituto Nacional De Salud Mental "Honorio Delgado - Hideyo Noguchi" is a Mental Health Care company and founded in 1982. It has approximately 238 employees on record. Contact data was last refreshed in June 2026. Find Instituto Nacional De Salud Mental "Honorio Delgado - Hideyo Noguchi"'s verified employee emails, phone numbers, headquarters address, and key decision makers below.

Bienvenidos a la cuenta oficial del Instituto Nacional de Salud Mental “Honorio Delgado - Hideyo Noguchi” del Ministerio de Salud del Perú. Somos una entidad pública especializada en Salud Mental, que innova, investiga, desarrolla y transfiere nuevas tecnologías a través de la docencia, capacitación, atención altamente especializada y propone normas que fortalecen la rectoría del Sector Salud y contribuyen al desarrollo de la población nacional con proyección internacional.
Looking for a particular Instituto Nacional De Salud Mental "Honorio Delgado - Hideyo Noguchi" employee's phone or email?

Instituto Nacional De Salud Mental "honorio Delgado - Hideyo Noguchi" Questions

News

Published on: 2025-10-27 16:14:51 - Fundação Cultural do Pará

Published on: 2025-10-27 16:14:51 Fundação Cultural do Pará

Ohio Retirement Fund Invests in Insmed Incorporated (INSM) - Yahoo Finance

Ohio Retirement Fund Invests in Insmed Incorporated (INSM) Yahoo Finance

Is INSM stock a defensive play in 2025 - July 2025 News Drivers & AI Enhanced Trade Execution Alerts - Trung tâm Dự báo KTTV quốc gia

Is INSM stock a defensive play in 2025 - July 2025 News Drivers & AI Enhanced Trade Execution Alerts Trung tâm Dự báo KTTV quốc gia

FERC Responds to ERO’s INSM Clarification Filing - RTO Insider

FERC Responds to ERO’s INSM Clarification Filing RTO Insider

Insmed Incorporated (INSM) Rallies After FDA Approves Brinsupri, Shares Jump 9% - Insider Monkey

Insmed Incorporated (INSM) Rallies After FDA Approves Brinsupri, Shares Jump 9% Insider Monkey

Goldman's 48 potential M&A candidates (INSM:NASDAQ) - Seeking Alpha

Goldman's 48 potential M&A candidates (INSM:NASDAQ) Seeking Alpha

Notable ETF Outflow Detected - XBI, ALNY, INSM, HALO - Nasdaq

Notable ETF Outflow Detected - XBI, ALNY, INSM, HALO Nasdaq

Here's Why Insmed Incorporated's (NASDAQ:INSM) CEO May Have Their Pay Bumped Up - simplywall.st

Here's Why Insmed Incorporated's (NASDAQ:INSM) CEO May Have Their Pay Bumped Up simplywall.st

Prevalence of anxiety disorders in Latin America: a systematic review and meta-analysis - The Lancet

Prevalence of anxiety disorders in Latin America: a systematic review and meta-analysis The Lancet

Insmed (INSM) Reported Impressive Results from the Phase 2 Trial of Its Inhalation Powder - Yahoo Finance

Insmed (INSM) Reported Impressive Results from the Phase 2 Trial of Its Inhalation Powder Yahoo Finance

How INSM stock performs during Fed tightening cycles - Trade Entry Summary & Free High Return Stock Watch Alerts - Trung tâm Dự báo KTTV quốc gia

How INSM stock performs during Fed tightening cycles - Trade Entry Summary & Free High Return Stock Watch Alerts Trung tâm Dự báo KTTV quốc gia

What Makes Insmed Incorporated (INSM) an Investment Bet? - Insider Monkey

What Makes Insmed Incorporated (INSM) an Investment Bet? Insider Monkey

Insmed (INSM) Reports Increased Losses But Reiterates 2025 Revenue Guidance - Yahoo Finance

Insmed (INSM) Reports Increased Losses But Reiterates 2025 Revenue Guidance Yahoo Finance

Volume Report: Is INSM stock a defensive play in 2025 - Trade Signal Summary & Short-Term High Return Ideas - Trung tâm Dự báo KTTV quốc gia

Volume Report: Is INSM stock a defensive play in 2025 - Trade Signal Summary & Short-Term High Return Ideas Trung tâm Dự báo KTTV quốc gia

Will Insmed (INSM) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance

Will Insmed (INSM) Report Negative Earnings Next Week? What You Should Know Yahoo Finance

Don't Overlook Insmed (INSM) International Revenue Trends While Assessing the Stock - Yahoo Finance

Don't Overlook Insmed (INSM) International Revenue Trends While Assessing the Stock Yahoo Finance

Strong Drug Development Momentum Lifted Insmed Incorporated (INSM) in Q2 - Yahoo Finance

Strong Drug Development Momentum Lifted Insmed Incorporated (INSM) in Q2 Yahoo Finance

Insmed Incorporated (INSM) Soars on Positive PAH Therapy Trial Results - Yahoo Finance

Insmed Incorporated (INSM) Soars on Positive PAH Therapy Trial Results Yahoo Finance

Goldman Sachs Hikes Insmed (INSM) Price Target to $112 Affirms Buy Rating - Yahoo Finance

Goldman Sachs Hikes Insmed (INSM) Price Target to $112 Affirms Buy Rating Yahoo Finance

Insmed Incorporated (INSM): Insiders Were Dumping in Q1 2025 - Yahoo Finance

Insmed Incorporated (INSM): Insiders Were Dumping in Q1 2025 Yahoo Finance

Should Insmed’s (INSM) EMA Nod for BRINSUPRI Prompt a Fresh Look at Its Growth Prospects? - Yahoo Finance

Should Insmed’s (INSM) EMA Nod for BRINSUPRI Prompt a Fresh Look at Its Growth Prospects? Yahoo Finance

Insmed (INSM) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Insmed (INSM) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates Yahoo Finance

Goldman Sachs Maintains Insmed (INSM) Buy Recommendation - Nasdaq

Goldman Sachs Maintains Insmed (INSM) Buy Recommendation Nasdaq

Insmed Incorporated (INSM): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying - Yahoo Finance

Insmed Incorporated (INSM): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying Yahoo Finance

Guru Fundamental Report for INSM - Benjamin Graham - Nasdaq

Guru Fundamental Report for INSM - Benjamin Graham Nasdaq

Wells Fargo Lifts Price Target on Insmed Incorporated (INSM) to $119 From $107 - Yahoo Finance

Wells Fargo Lifts Price Target on Insmed Incorporated (INSM) to $119 From $107 Yahoo Finance

Insmed (INSM) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates - Nasdaq

Insmed (INSM) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates Nasdaq

How FDA Approval of BRINSUPRI for NCFB at Insmed (INSM) Has Changed Its Investment Story - Yahoo Finance

How FDA Approval of BRINSUPRI for NCFB at Insmed (INSM) Has Changed Its Investment Story Yahoo Finance

Insider Sale: Director at $INSM Sells 10,000 Shares - Quiver Quantitative

Insider Sale: Director at $INSM Sells 10,000 Shares Quiver Quantitative

New Analyst Forecast: $INSM Given $193.0 Price Target | INSM Stock News - Quiver Quantitative

New Analyst Forecast: $INSM Given $193.0 Price Target | INSM Stock News Quiver Quantitative

Insmed (INSM) Gains As FDA Approves BRINSUPRI For New Market - simplywall.st

Insmed (INSM) Gains As FDA Approves BRINSUPRI For New Market simplywall.st

New Analyst Forecast: $INSM Given 'Outperform' Rating - Quiver Quantitative

New Analyst Forecast: $INSM Given 'Outperform' Rating Quiver Quantitative

What Does Wall Street Think About Insmed Incorporated (INSM)? - Insider Monkey

What Does Wall Street Think About Insmed Incorporated (INSM)? Insider Monkey

October 17th Options Now Available For Insmed (INSM) - Nasdaq

October 17th Options Now Available For Insmed (INSM) Nasdaq

Insmed Incorporated (INSM): Among Takeover Rumors Hedge Funds Are Buying - Yahoo Finance

Insmed Incorporated (INSM): Among Takeover Rumors Hedge Funds Are Buying Yahoo Finance

Insmed downgraded at Morgan Stanley despite FDA nod for lung therapy - Seeking Alpha

Insmed downgraded at Morgan Stanley despite FDA nod for lung therapy Seeking Alpha

TD Cowen Raises Price Target for Insmed (INSM) to $193 | INSM St - GuruFocus

TD Cowen Raises Price Target for Insmed (INSM) to $193 | INSM St GuruFocus

Insmed Announces Massive $650M Stock Offering with Goldman Sachs, Leerink as Underwriters - Stock Titan

Insmed Announces Massive $650M Stock Offering with Goldman Sachs, Leerink as Underwriters Stock Titan

Goldman Sachs Raises Insmed (INSM) Price Target to $196 | INSM S - GuruFocus

Goldman Sachs Raises Insmed (INSM) Price Target to $196 | INSM S GuruFocus

Noteworthy ETF Outflows: XBI, CRSP, RVMD, INSM - Nasdaq

Noteworthy ETF Outflows: XBI, CRSP, RVMD, INSM Nasdaq

Lung Disease-Focused Insmed 'Must-Own' Name For Investors - Benzinga

Lung Disease-Focused Insmed 'Must-Own' Name For Investors Benzinga

Insmed (INSM) Secures $750 Million Through Stock Offering - GuruFocus

Insmed (INSM) Secures $750 Million Through Stock Offering GuruFocus

Noteworthy Tuesday Option Activity: DXC, DK, INSM - Nasdaq

Noteworthy Tuesday Option Activity: DXC, DK, INSM Nasdaq

Insmed (INSM) Receives Price Target Increase from Wells Fargo | - GuruFocus

Insmed (INSM) Receives Price Target Increase from Wells Fargo | GuruFocus

Investing in Insmed (NASDAQ:INSM) five years ago would have delivered you a 308% gain - simplywall.st

Investing in Insmed (NASDAQ:INSM) five years ago would have delivered you a 308% gain simplywall.st

Insmed Reports First-Quarter 2024 Financial Results and Provides Business Update - PR Newswire

Insmed Reports First-Quarter 2024 Financial Results and Provides Business Update PR Newswire

Prevalence of depressive disorder in the adult population of Latin America: a systematic review and meta-analysis - The Lancet

Prevalence of depressive disorder in the adult population of Latin America: a systematic review and meta-analysis The Lancet

Propiedades psicométricas de la escala de salud mental positiva en Arequipa (Perú) - SciELO España

Propiedades psicométricas de la escala de salud mental positiva en Arequipa (Perú) SciELO España

INSM Stock Price and Chart — NASDAQ:INSM - TradingView

INSM Stock Price and Chart — NASDAQ:INSM TradingView

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant